Rejuvenate Biomed is a science-based healthy aging company dedicated to developing prescription drugs that promote healthy aging. As a clinical-stage biotech organization, their focus is on discovering and creating therapeutics that can delay the onset of multiple age-related diseases. Their cutting-edge therapy, RJx-01, has shown promising results in clinical trials, demonstrating improvements in muscle strength, function, and fatigue resistance for individuals suffering from sarcopenia.

Published data on animal studies revealed significant increases in muscle mass, strength, and physical performance in sarcopenia mouse models. Committed to a sustainable future, Rejuvenate Biomed has identified core Sustainable Development Goals and taken actions to achieve these goals. With a mission to promote healthy aging, they are driven by a dedication to innovation and improving the quality of life for millions